Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT

Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT

More Studies Required “However, recent observations of oral intolerability at the current dose and formulation, in a subset of patients, in both studies, indicate that more formulation and dose-ranging studies are required, which is challenging for the Company based upon our current resources,” Dr. McVicar added. In November, Flex Pharma trumpeted positive topline data in […]

Galactorrhea

Galactorrhea

Galactorrhea is the spontaneous flow of milk from the breast in a woman who is not pregnant or nursing a child. It can occur both in men and women. The milky discharge is from both the breasts and the milk may be secreted spontaneously or expressed. Though galactorrhea itself cannot be considered as a disease […]

Flex Pharma to cut 60 percent of workforce

Flex Pharma to cut 60 percent of workforce

June 13 (Reuters) – U.S. drug developer Flex Pharma Inc said on Wednesday it plans to reduce its workforce by 60 percent, as part of a restructuring, and was ending certain ongoing mid-stage trials. The company will now focus on developing its Amyotrophic lateral sclerosis (ALS) drug, FLX-787, the company’s lead product candidate, for dysphagia […]

Cautious SA consumers are spending more on pharma goods, Mastercard survey shows

Cautious SA consumers are spending more on pharma goods, Mastercard survey shows

South Africans spent less on food and more on pharmaceuticals in April, according to credit and debit card issuer Mastercard. Mastercard released its monthly SpendingPulse survey for April shortly before Statistics SA was scheduled to release is retail sales figures for April at 1pm. Mastercard’s data showed annual spending growth of 3.7% in April from […]

Indian drugmaker Sun Pharma says Halol plant has gained US clearance

Indian drugmaker Sun Pharma says Halol plant has gained US clearance

MUMBAI (Reuters) – Supply restrictions imposed on India’s largest drugmaker Sun Pharmaceutical Industries by U.S. regulators have been lifted, the company said on Tuesday, removing a major drag on its share price. Sun will now be able to resume shipments of drugs made at its Halol factory in western India, which contributed as much as […]

Market Update: Pharma stocks rally with Sun Pharma, Lupin up 2%; Infosys, D-Mart hit fresh 52-week high

Market Update: Pharma stocks rally with Sun Pharma, Lupin up 2%; Infosys, D-Mart hit fresh 52-week high

The broader indices continued to trade higher this Wednesday morning with the Nifty gaining 35 points at 10,878 and the Sensex added 134 points at 35,826. The midcap index was up over half a percent led by Mcleod Russel, Strides Shasun, Biocon and Bank of India. Pharma stocks gained the most led by Sun Pharmaceutical Industries, Cadila Healthcare, […]

Can This Pharma's $14 Billion Bet Succeed?

Can This Pharma's $14 Billion Bet Succeed?

A couple of years back, Pfizer Inc. (NYSE:PFE) took a lot of heat in order to pull off a massive $14 billion acquisition that added Xtandi and a potential new cancer drug called talazoparib to its pipeline. At the time, America’s biggest pharma quelled investor skepticism with confident boasting that talazoparib would easily outperform a […]

Pharma on recovery path becomes a darling of mutual funds

Pharma on recovery path becomes a darling of mutual funds

MUMBAI: Mutual funds are lining up products to invest in pharma stocks that have been battered in the past three years. Mirae Asset and ICICI Prudential have already launched their NFOs in the space, while Aditya Birla Sun Life has applied with market regulator Sebi to start one. Fund managers believe that share valuations of […]

Sun Pharma finally free of FDA restrictions on its key plant in India

Sun Pharma finally free of FDA restrictions on its key plant in India

After more than two years of intense effort, Sun Pharma has returned its key plant to the good graces of the FDA. Being free of the restrictions tied to a 2015 warning letter makes it possible for India’s largest drugmaker to again launch products in the U.S. from the Halol facility and accelerate its financial […]